OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Acquired hypothalamic obesity: A clinical overview and update
Christian L. Roth, Shana E. McCormack
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S2, pp. 34-45
Closed Access | Times Cited: 9
Christian L. Roth, Shana E. McCormack
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S2, pp. 34-45
Closed Access | Times Cited: 9
Showing 9 citing articles:
Treatment of patients with tumor/treatment-related hypothalamic obesity in the first two years following surgical treatment or radiotherapy
Hermann L. Müller, Julian Witte, Bastian Surmann, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hermann L. Müller, Julian Witte, Bastian Surmann, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Junting Xie, Rui Cai, Xiaoning Hou, et al.
Journal of the Science of Food and Agriculture (2025)
Closed Access
Semaglutide as a promising treatment for hypothalamic obesity: a six-month case series on four females with craniopharyngioma
Erlend Gjersdal, Liva Bundgaard Larsen, Kåre Schmidt Ettrup, et al.
Pituitary (2024) Vol. 27, Iss. 5, pp. 723-730
Open Access | Times Cited: 2
Erlend Gjersdal, Liva Bundgaard Larsen, Kåre Schmidt Ettrup, et al.
Pituitary (2024) Vol. 27, Iss. 5, pp. 723-730
Open Access | Times Cited: 2
3,5-dimethyl-2,4,6-trimethoxychalcone Lessens Obesity and Metabolic Dysfunction-Associated Fatty <i>Liver</i> Disease (MAFLD) in Leptin-Deficient ob/ob Mice
Stéphanie Gaigé, Anne Abysique, Rym Barbouche, et al.
(2024)
Open Access | Times Cited: 1
Stéphanie Gaigé, Anne Abysique, Rym Barbouche, et al.
(2024)
Open Access | Times Cited: 1
From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics
Amedeo Lonardo, Ralf Weiskirchen
Metabolites (2024) Vol. 14, Iss. 8, pp. 408-408
Open Access
Amedeo Lonardo, Ralf Weiskirchen
Metabolites (2024) Vol. 14, Iss. 8, pp. 408-408
Open Access
Is semaglutide a target therapy for acquired hypothalamic obesity?
Flavia Prodam
Pituitary (2024)
Open Access
Flavia Prodam
Pituitary (2024)
Open Access
3,5-Dimethyl-2,4,6-trimethoxychalcone Lessens Obesity and MAFLD in Leptin-Deficient ob/ob Mice
Stéphanie Gaigé, Anne Abysique, Rym Barbouche, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9838-9838
Open Access
Stéphanie Gaigé, Anne Abysique, Rym Barbouche, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9838-9838
Open Access
Hypothalamic obesity: from basic mechanisms to clinical perspectives
Jesús Argente, I. Sadaf Farooqi, Julie A. Chowen, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 13, Iss. 1, pp. 57-68
Closed Access
Jesús Argente, I. Sadaf Farooqi, Julie A. Chowen, et al.
The Lancet Diabetes & Endocrinology (2024) Vol. 13, Iss. 1, pp. 57-68
Closed Access
Effects of growth hormone replacement therapy in childhood-onset craniopharyngioma: an updated systematic review and meta-analysis
Mylena Maria Guedes de Almeida, Pedro Henrique Aquino Gil de Freitas, Áurea Maria Salomão Simão, et al.
Pituitary (2024) Vol. 28, Iss. 1
Closed Access
Mylena Maria Guedes de Almeida, Pedro Henrique Aquino Gil de Freitas, Áurea Maria Salomão Simão, et al.
Pituitary (2024) Vol. 28, Iss. 1
Closed Access
